Volume 4 - Issue 2 - March/April 2007

Frank J. Criado

In 2005, more than 90% of non-coronary endovascular stent use (by physicians performing vascular intervention) was off-label. It dropped to a “low” of approximately 60% in 2006. Astonishingly, the on-label indication for the vast majority of such… | Read More

Edgardo Zavala-Alarcon, MD, Lisa Emmans, MD, Ankur Bant, MD

Introduction The sinuses of Valsalva are three small dilatations or cavity-like structures in the aortic wall above the attachments of the aortic cusps. They are known as the right coronary, left coronary and non-coronary sinuses, as defined by the… | Read More

David E. Allie, MD

In this issue of Vascular Disease Management, Zavala-Alarcon et al1 present an interesting look at an uncommon cardiovascular problem and the unique opportunity to “witness” a potentially highly morbid event if not diagnosed and treated properly.… | Read More

Shyamkumar Nidugala Keshava, DNB, FRCR, FRANZCR and Ruben Sebben, FRANZCR

Introduction Distal renal artery perforation during renal arterial stenting with a guidewire is an uncommon but potentially fatal complication.1 Although guidewire perforation leading to subcapsular or perirenal hematoma may be successfully managed… | Read More

Boulos Toursarkissian, MD, Mehmet Cilingiroglu, MD, Ryan Hagino, MD, Michael Wholey, MD, Lisa Veale, PA-C

Introduction Iliac stenting for occlusive atherosclerotic disease is an accepted therapeutic modality. Completely occluded iliac arteries can be wire recanalized with a high degree of success1 and acceptable long-term results. The technical aspects… | Read More

<sup>1</sup>Mark A. Perazella, MD and <sup>2</sup>Roger A. Rodby, MD

Physicians are constantly introduced to new diagnostic and therapeutic modalities developed to enhance patient care. However, adverse effects of these technological advances often come to light only when they are later widely employed in clinical… | Read More

Shazia T. Hussain, MD, MRCP and Diana A. Gorog, MD, PhD, MRCP

Background Arterial atherosclerosis can affect any organ in the body, and its consequences are devastating and potentially life threatening. Myocardial infarction (MI), stroke and peripheral vascular disease (PVD) are all commonplace throughout both… | Read More

<sup>1</sup>Hutton P. Brantley, DO and <sup>2</sup>Farrell O. Mendelsohn, MD

Introduction The Stenting and Angioplasty with Protection In Patients at High Risk for Endarterectomy (SAPPHIRE) trial demonstrated that among patients with severe carotid artery stenosis and significant comorbid conditions, carotid stenting with… | Read More